LAG3 and neoplasm: Lymphocyte activation gene-3 (LAG-3 or CD223), first discovered in 1990, is a transmembrane protein (498 amino acids) expressed primarily on the surface of activated T lymphocytes and NK cells (107) but has also been demonstrated in APCs and certain tumor cell lines (108).